Podcast Episodes
Back to SearchInhalable mAbs & Vaccines with TFF's Glenn Mattes
We love to hear from our listeners. Send us a message.
Glenn Mattes' TFF Pharmaceuticals is looking to break the parenteral barrier by manufacturing …
4 years, 4 months ago
Democratizing Biologics With Lumen Bioscience's Brian Finrow, J.D. & Craig Behnke, Ph.D.
We love to hear from our listeners. Send us a message.
Making powerful and curative biologic therapies accessible to patients from all walks of life,…
4 years, 4 months ago
Cornering The Antibody Market With Akesobio CEO Dr. Michelle Xia, Ph.D.
We love to hear from our listeners. Send us a message.
In business for just a decade, Akesobio's stats are mindboggling: 20 drug development programs…
4 years, 4 months ago
Turning The Liver Into A mAb Factory With Homology's Arthur Tzianabos, Ph.D.
We love to hear from our listeners. Send us a message.
Homology Medicines' approaches to gene therapy and gene editing have the potential to seriousl…
4 years, 5 months ago
Maximizing mRNA With Precision Nanosystems' James Taylor, Ph.D.
We love to hear from our listeners. Send us a message.
Dr. James Taylor believes that genomic medicine will prove the most revolutionary thing the li…
4 years, 5 months ago
Foundations Of Flexible Manufacturing With Sarepta Therapeutics' Brian Winstead
We love to hear from our listeners. Send us a message.
Is "flexible manufacturing" just another empty buzz concept concocted by the biopharma equipme…
4 years, 5 months ago
The CDMO Capacity Crunch With Discovery Labs' Audrey Greenberg and Iovance Biotherapeutics' Sumit Verma
We love to hear from our listeners. Send us a message.
While nary a day goes by without a shovel breaking ground on a new CDMO buildout, biopharmas r…
4 years, 5 months ago
The Clinical Trials Conundrum with Allan Shaw
We love to hear from our listeners. Send us a message.
The clinical trials status quo is a roadblock. They're slow, they're inefficient, and they're …
4 years, 6 months ago
CMC Developability Assessments For Rapid Ph.1 Entry with AltruBio's Gene Lee, Ph.D.
We love to hear from our listeners. Send us a message.
Fresh on the heels of an outstanding talk with AltruBio President & CEO Judy Chou, Ph.D., the …
4 years, 6 months ago
CDMO With A Pipeline with Forge Biologics President & CEO Dr. Timothy J. Miller
We love to hear from our listeners. Send us a message.
Inspired to develop a treatment for Infantile Krabbe Disease, the founders of Forge Biologics …
4 years, 6 months ago